KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,387 | +391.3% | 13,955 | +359.2% | 0.00% | – |
| Q2 2023 | $27,351 | +351.0% | 3,039 | +238.8% | 0.00% | – |
| Q4 2022 | $6,064 | -87.1% | 897 | -66.6% | 0.00% | – |
| Q3 2021 | $47,000 | +4.4% | 2,689 | +42.0% | 0.00% | – |
| Q2 2021 | $45,000 | -44.4% | 1,894 | -40.2% | 0.00% | – |
| Q1 2021 | $81,000 | +1925.0% | 3,169 | +1423.6% | 0.00% | – |
| Q4 2020 | $4,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |